TCMBANKIN005092 |
methyl-4-o-methylgallate |
3,5-Dihydroxy-4-methoxybenzoic acid methyl ester; Benzoic acid, 3,5-dihydroxy-4-methoxy-, methyl ester; AC1NSYID; FCH837428; FT-0699716; ZINC14775842; SCHEMBL2728130; Methyl-4-O-methylgallate; ACM24093810; CHEMBL491990; AKOS006283782; CTK0J5233; DTXSID20415758; MFCD00017195; 24093-81-0; AK550949; M2794; methyl 3,5-dihydroxy-4-methoxybenzoate; Benzoic acid,3,5-dihydroxy-4-methoxy,methyl ester |
C9H10O5 |
198.17 g/mol |
COC1=C(C=C(C=C1O)C(=O)OC)O |
TCMBANKIN009132 |
chrysotoxene |
|
C18H18O5 |
314.33 |
COC1=C(C(=C2C(=C1)C=CC3=C2C=CC(=C3OC)O)OC)OC |
TCMBANKIN031535 |
chrysoobtusin |
AJ-55628; BDBM50133044; KB-230773; AX8245768; 2-HYDROXY-1,6,7,8-TETRAMETHOXY-3-METHYL-9,10-DIHYDROANTHRACENE-9,10-DIONE; AK120352; DTXSID30220870; Chryso-obtusin; 4CH-024754; 2-hydroxy-1,6,7,8-tetramethoxy-3-methylanthracene-9,10-dione; ZINC6070309; BG01338509; SCHEMBL16226057; AC1L4E61; 0935AC; CHEMBL461085; ST24040662; 9,10-Anthracenedione, 2-hydroxy-1,6,7,8-tetramethoxy-3-methyl-; Chrysoobtusin; CHEBI:81263; 2-hydroxy-1,6,7,8-tetramethoxy-3-methylanthraquinone; 70588-06-6; AKOS016010638; C17669 |
C19H18O7 |
358.3 g/mol |
CC1=CC2=C(C(=C1O)OC)C(=O)C3=C(C(=C(C=C3C2=O)OC)OC)OC |
TCMBANKIN039035 |
Chrysosplenol E |
|
|
374.3 g/mol |
|
TCMBANKIN060186 |
methyl 2-o-methyl platyconate a |
|
C59H94O29 |
|
CC1C(C(C(C(O1)OC2C(C(COC2OC(=O)C34CCC(CC3C5=CCC6C(C5(CC4O)C)(CCC7C6(CC(C(C7(CO)C(=O)OC)OC8C(C(C(C(O8)CO)O)O)O)OC)C)C)(C)C)O)O)O)O)OC9C(C(C(CO9)O)OC1C(C(CO1)(CO)O)O)O |
TCMBANKIN061721 |
chrysograyanin |
oxyayanin a |
C18H16O8 |
360.3 g/mol |
COC1=CC(=C2C(=C1)OC(=C(C2=O)OC)C3=CC(=C(C=C3O)OC)O)O |
TCMBANKIN061722 |
chrysosplenol g |
5,3'-dihydroxy-3,7,4',5'-tetramethoxyflavone |
C19H18O8 |
374.3 g/mol |
COC1=CC(=C2C(=C1)OC(=C(C2=O)OC)C3=CC(=C(C=C3OC)OC)O)O |